| Janssen-Cilag AG - Eprex 4000 U, Injektionslösung (Fertigspritzen) |
| 49078 | | 21 | | Eprex 4000 U | | Injektionslösung (Fertigspritzen) | | B03XA01 | | Erythropoietin | | 24.07.1998 | | |
|
| Composition |
| epoetinum alfa 4000 U.I., polysorbatum 80, natrii chloridum, natrii dihydrogenophosphas dihydricus, dinatrii phosphas dihydricus, glycinum, aqua ad iniectabile q.s. ad solutionem pro 0.4 ml corresp. natrium 1.235 mg. |
| Packungsbestandteile |
| Injection solution in prefilled syringe | | | | | | | | Active Agent | Dose |
|---|
| Epoetin Alfa | 4000U.I. / 0.4ml |
| | BAG: Active Agent | Dose |
|---|
| Epoetinum alfa Adnr | 4000 UI |
| | | | Inactive agents |
|---|
| Disodium Phosphate Dihydrate | | Glycin | | Sodium Chloride | | Sodium Dihydrogenophosphate Dihydrate | | Polysorbatum 80 |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 807 | 6 1 syringe(s) à 0.4 ml | 165.72 | 195.65 | A | SL | No |
|